Indegene IPO: Price, Lot Size, Strengths and Risks

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Indegene Limited, a leader in the global life science sector, serves more than 52 clients all over the globe. The company offers solutions to its clients from different operational centres located in Europe, North America and Asia. Recently, it has developed AI and machine learning-based platforms to offer solutions to clients. 

The company is planning to launch its IPO to raise funds amounting to Rs. 1,841.76 crores, comprising a fresh issue of Rs. 760 crores and an offer for sale of up to 2.39 crore shares. Continue reading this blog to gain detailed insights about Indegene Limited IPO, its lot size, strengths, weaknesses and more. 

Indegene Limited IPO Details

Indegene Limited IPO will open for subscription from May 6, 2024, and end on May 8, 2024. Here is a detailed overview of Indegene Limited's IPO details:

Additional Read: Upcoming IPOs in May 2024

IPO Opening Date

May 6, 2024

IPO Closing Date

May 8, 2024

IPO Listing Date

May 13, 2024 

Issue Type

Book Built Issue IPO

Face Value

Rs. 2 per share

Price Band

Rs. 430 to Rs. 452 per share

Minimum Lot Size


Total Issue Size


(aggregating up to Rs. 1,841.76 crore)

Fresh Issue Size


(aggregating up to Rs. 760.00 Cr)

Offer for Sale

2,39,32,732 shares of Rs. 2

(aggregating up to Rs. 1,081.76 Cr)

Listed On


Additional Read: How to Invest in an IPO Online

About the Company

Incorporated in 1998, Indegene Limited is a leading provider of commercialization services focusing solely on the global life science industry. The companies involved in this industry include emerging biotech, biopharmaceutical and medical devices. 

Life sciences enterprise showcases the journey of a drug from research lab to market for organizing clinical data and noticing the ethical guidelines following which the industry operates. These companies also develop authorized content for patients and healthcare professionals. 

Indegene plays an important role in developing products, introducing them in the market and generating sales most efficiently. It caters to the needs of companies offering them services that range from the development of drugs to sales and providing marketing support.  The company's services are further subdivided into four categories, namely, Omni channel Activation, Enterprise Commercial Solutions, Enterprise Clinical Solutions and Consultancy Services, and Enterprise Medical Solutions. 

IPO Tentative Timeline

The table below displays the tentative timeline of Indegene Limited IPO:

IPO Open Date

Monday, May 6, 2024

IPO Close Date

Wednesday, May 8, 2024

Basis of Allotment

Thursday, May 9, 2024

Initiation of Refunds

Friday, May 10, 2024

Credit of Shares to Demat

Friday, May 10, 2024

Listing Date

Monday, May 13, 2024

Cut-off Time for UPI Mandate Confirmation

5 PM on May 8, 2024

IPO Lot Size

As an investor, you can bid for 33 shares minimum. Here is the table portraying the minimum and maximum investments retail investors can make in terms of shares and amount:





Retail (Min)



Rs. 14,916

Retail (Max)



Rs. 193,908

S-HNI (Min)



Rs. 2,08,824

S-HNI (Max)



Rs. 9,99,372

B-HNI (Min)



Rs. 1,014,288

Additional Read: Difference Between NFO and IPO

Company Financials

Between the financial year 2022 and 2023, the revenue of Indegene Limited IPO increased by 39.85% while the profit after tax by 63.43%. Here is a detailed overview of the financial statement of Indegene Limited IPO:


                      For the Financial Year Ending (in Rupees Million)


March 31, 2021

March 31, 2022

March 31, 2023









Profit After Tax




Net Worth




Reserves and Surplus




Total Borrowing





Before investing in an IPO, you must be aware of its strengths and weaknesses. Here are the strengths of Indegene Limited IPO:

  • The domain expertise in healthcare allows Indegene Limited to use advanced technology in optimising sales and costs of marketing. It also improves the recruitment process among patients through clinical trials. Because it continuously provides life cycle companies with end-to-end capabilities and expertise, it received the "Special Recognition Award for Innovation in Health" in 2016 from the Organisation of Pharmaceutical Producers of India. 
  • The company is well known for establishing long-standing relationships with biopharmaceutical companies in the world. This is evident from the retention rates of 159.89%, 129.90% and 113.30% during the financial years 2022, 2021 and 2020. Moreover, Indegene Limited has not faced a fall in revenue from any of its leading clients during the past three financial years. 
  • Indegene consists of experienced employees from different domains who assist clients across the region. The organisation builds up a culture focusing on employees. The human resource policies and practices have helped the company to earn recognition as one of the best companies since 2016. 

Risks Involved

Besides strengths, there are also certain risks associated with Indegene Limited IPO. The risks are: 

  • If the company fails to meet the requirements of the client, it will adversely affect its cash flows and overall business operations.
  • The company is subjected to the protection of data and other laws. Any failure to meet such laws might damage the reputation of Indegene Limited IPO. 


By now, you must have a clear understanding of Indegene Limited IPO along with a detailed overview of its strengths and weaknesses. However, make sure to go through the Red Herring Prospectus (RHP) of the company before starting to invest in this IPO. 

You can find detailed information about this on our official website. In the meantime, you must ensure to open a trading and demat account, if you have not already, to ease your journey of investment.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here:

Share this article: 

Frequently Asked Questions

Where are the equity shares of Indegene Limited IPO proposed to be listed?

Answer Field

The equity shares of Indegene Limited IPO are proposed to be listed on the Bombay Stock Exchange and National Stock Exchange.

Who is the registrar of Indegene Limited IPO?

Answer Field

Link Intime India Private Limited is the registrar of Indegene Limited IPO.

Who are the book-running lead managers of Indegene Limited IPO?

Answer Field

Citigroup Global Markets India Private Limited, Kotak Mahindra Capital Company Limited, Nomura Financial Advisory and Securities (India) Private Limited and J.P. Morgan India Private Limited are the book-running lead managers of Indegene Limited IPO.

What is the face value of equity shares of Indegene Limited IPO?

Answer Field

The face value of equity shares of Indegene Limited IPO is Rs. 2 per share.

What is the price band of the Indegene Limited IPO?

Answer Field

The price band of Indegene Limited IPO ranges between Rs. 430 to Rs. 452.

No Result Found

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users


4.3+ App Rating


4 Languages


₹4300 Cr MTF Book